facility, clinical characteristics at kidney biopsy (age, gender, smoking status, hyperten- sion, eGFR, urinary protein, and urinary occult blood); ACE I/D and therapeutic interventions within one year of kidney biopsy (RAS blockade and use of immunosuppressants) 